gip glp 1 agonist Possible mechanisms of the interaction of and GLP-1 for treatment The dual glucose-dependent insulinotropic polypeptide
Description
[16] The FDA granted the approval of Zepbound to Eli Lilly
This activation enhances glucose-dependent insulin secretion, suppresses inappropriate glucagon release, delays gastric emptying, and reduces appetite through central nervous system pathways
FOR GLP-1 MEDICATION SIDE EFFECTS SOURCE: Collins L, Costello RA
GLP-1 medications work by mimicking a natural hormone in your body
